MedPath

Investigation about treatment of midnight hypertension in diabetes

Phase 2
Conditions
hypertension in diabetes
Registration Number
JPRN-UMIN000002205
Lead Sponsor
Division of diabetes, metabolism and Endocrinology Department od Internal Medicine, Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) drug allergy to ARB or Ca antagonist 2) pregnant women or possible pregnant women 3) using anti-fugal drug or HIV protease inhibitor 4) bilateral renal artery stenosis or unilateral renal artery stenosis of remnant kidny

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath